Does RUXOLITINIB Cause Haemoglobin increased? 332 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 332 reports of Haemoglobin increased have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.5% of all adverse event reports for RUXOLITINIB.
332
Reports of Haemoglobin increased with RUXOLITINIB
0.5%
of all RUXOLITINIB reports
12
Deaths
58
Hospitalizations
How Dangerous Is Haemoglobin increased From RUXOLITINIB?
Of the 332 reports, 12 (3.6%) resulted in death, 58 (17.5%) required hospitalization, and 12 (3.6%) were considered life-threatening.
Is Haemoglobin increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 332 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Haemoglobin increased?
TREPROSTINIL (245)
SOTATERCEPT (151)
CLOZAPINE (142)
SOTATERCEPT-CSRK (100)
DARBEPOETIN ALFA (99)
TESTOSTERONE (96)
METFORMIN (93)
VOXELOTOR (86)
ROSUVASTATIN (85)
ADALIMUMAB (81)
Which RUXOLITINIB Alternatives Have Lower Haemoglobin increased Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE